Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity.
about
Kidney xenotransplantationImmunobiological barriers to xenotransplantationSequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.Coagulation dysregulation as a barrier to xenotransplantation in the primatePathologic characteristics of transplanted kidney xenografts.Potential factors influencing the development of thrombocytopenia and consumptive coagulopathy after genetically modified pig liver xenotransplantation.Overcoming the barriers to xenotransplantation: prospects for the futureCurrent status of xenotransplantation and prospects for clinical applicationProgress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literatureXenotransplantation literature update July-August, 2004.Endothelial cell protection in xenotransplantation: looking after a key player in rejection.Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboonsGal knockout and beyond.Minimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: a pilot study.Antibody-mediated xenograft injury: mechanisms and protective strategies.Early graft failure of GalTKO pig organs in baboons is reduced by expression of a human complement pathway-regulatory protein.Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era.The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options.Current status of pig kidney xenotransplantationThe pathobiology of pig-to-primate xenotransplantation: a historical review.Regulation of human platelet aggregation by genetically modified pig endothelial cells and thrombin inhibition.Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti-nonGal IgG binding to porcine aortic endothelial cells.Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation.Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft's cytoprotection.Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells.Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function.Generation of CMAHKO/GTKO/shTNFRI-Fc/HO-1 quadruple gene modified pigs.3D artificial round section micro-vessels to investigate endothelial cells under physiological flow conditions.Increased human tumor necrosis factor-α levels induce procoagulant change in porcine endothelial cells in vitro.
P2860
Q26822638-E250C767-400F-4B0A-80A9-7F1DEA44B5A7Q28081993-04642843-AF5E-47E3-A0B4-108377570039Q33246284-78305FE7-BC70-4036-A2AE-77A3A75263D6Q33381973-778F65F7-F556-4C7E-947C-9D3694AA47A0Q33398429-2053D08E-653A-485A-9813-D3B7E34A0918Q33401474-C9C5EA7C-648E-4EC4-B00A-6D5200F6223DQ33801035-6029D39E-7D76-485C-82D2-B973A258BEEAQ33835678-848AB1D9-4462-457B-A134-4DCD97C2F9DEQ34250530-2923907E-2BB5-4011-AA4B-150926CEBCD8Q35915788-500C9127-8DD8-42F1-B1CE-F0E41D2E8456Q36404498-E9DF8F91-8AB9-4385-A82C-BAD1A41795D7Q36691036-A4F367FE-E23F-47EA-9B4E-E72E1CDDBF63Q36709669-08A7BD0E-C4F2-4853-932D-51AF68E2B6A4Q37361071-CC099EC4-998E-45FE-97CF-EE76506BE3D6Q37450148-7A5B4249-9787-40FF-B8EA-35BE68DF9E48Q37519520-64562D6E-43DE-4973-9D14-090AE0EAE557Q37919109-6FD7B5FE-3636-4735-8215-662CAF8AF929Q38191251-C5DFBBA9-4977-4B5E-946E-55541AD86557Q38573513-839C9FA2-884B-418F-A7C7-F215974DE9DAQ38712532-97329EDD-2286-45A4-A18C-CD96FAB32772Q39246204-4E070C95-72E4-4E69-9C13-0D50FAC26BACQ42395227-7FFF7E2D-51FB-4679-A56C-99A73BA19587Q42593720-18A118B7-4717-45C2-931E-3B69473537E0Q42742651-FC693588-BF90-4870-91B2-88356A09D1EAQ43185385-6F305D8A-C43C-42C8-809B-853501AD9488Q46427137-F4411924-7F9A-410E-9647-EC796A6B544AQ50200937-DB391C75-6DC2-43DB-9719-9672DF3B6AB7Q52590897-41A909A3-CC4D-4F07-A150-AC2778499503Q53162596-F9414CC7-E7D8-4261-A979-B2E0C965E7DE
P2860
Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Acute vascular rejection of xe ...... tion of procoagulant activity.
@ast
Acute vascular rejection of xe ...... tion of procoagulant activity.
@en
type
label
Acute vascular rejection of xe ...... tion of procoagulant activity.
@ast
Acute vascular rejection of xe ...... tion of procoagulant activity.
@en
prefLabel
Acute vascular rejection of xe ...... tion of procoagulant activity.
@ast
Acute vascular rejection of xe ...... tion of procoagulant activity.
@en
P2093
P921
P1433
P1476
Acute vascular rejection of xe ...... tion of procoagulant activity.
@en
P2093
Bernd Gollackner
David K C Cooper
Elzbieta Kaczmarek
Imrana Qawi
Leo Buhler
Michel Awwad
Seo Kiat Goh
Simon C Robson
Soizic Daniel
P304
P356
10.1097/01.TP.0000131167.21930.B8
P577
2004-06-01T00:00:00Z